Summary slide.png (64.17 kB)

Idarucizumab Reverses Dabigatran Anticoagulant Activity in Healthy Chinese Volunteers: A Pharmacokinetics, Pharmacodynamics and Safety Study

media

posted on 16.07.2020, 15:41 authored by Zining Wang, Xia Zhao, Pengkang He, Shuqing Chen, Jie Jiang, Akiko Harada, Steven Brooks, Yimin Cui

Article full text

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

History

References

https://link.springer.com/article/10.1007/s12325-020-01439-2

Usage metrics

Read the peer-reviewed publication

Idarucizumab Reverses Dabigatran Anticoagulant Activity in Healthy Chinese Volunteers: A Pharmacokinetics, Pharmacodynamics and Safety Study

Advances in Therapy

Keywords

Dabigatran etexilate Healthy Chinese subjects Idarucizumab Pharmacokinetic/pharmacodynamic Safety

Licence

CC BY-NC 4.0

Idarucizumab Reverses Dabigatran Anticoagulant Activity in Healthy Chinese Volunteers: A Pharmacokinetics, Pharmacodynamics and Safety Study

History

References

Usage metrics

Read the peer-reviewed publication

Categories

Keywords

Licence

Exports